Chemfab Alkalis profit and loss

Latest FY26

Revenue: ₹311cr−7.0% on FY25
EBITDA: ₹27.2cr−37.7% on FY25
Net profit: −₹3.4cr−₹6.9 cr in FY25
EPS: −₹2.38−₹4.86 in FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Sep 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Expenses
	292	311	334	327	331	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	8.0	8.7	7.1	8.5	5.5
	300	320	341	336	337
	95.1	95.0	102	73.6	48.4
	2.8	2.7	7.4	22.1	24.9
	−4.8	5.3	−9.8	2.4	−3.6
	26.9	26.3	25.5	23.4	19.3
	8.8	7.7	4.9	0.9	0.2
	31.1	28.4	36.3	22.4	22.9
	144	155	165	152	132
	304	320	332	297	244
	27.6	27.2	43.7	53.9	110
	−3.5	−1.2	7.4	31.5	87.5
Profit
	−4.3	−0.2	9.6	39.1	92.8
	0.0	0.0	−9.9	0.0	−3.4
	−4.3	−0.2	−0.3	39.1	89.4
	0.1	1.9	3.8	7.7	16.1
	−4.1	1.3	2.9	5.2	8.8
	−3.9	3.2	6.6	12.8	24.9
	−0.3	−3.4	−6.9	26.3	64.6
	−0.3	−3.4	−6.9	26.3	64.6
	0.7	0.6	0.4	0.2	−0.6
	0.4	−2.8	−6.6	26.5	63.9
	—	−3.4	—	—	64.6
Per share
	−₹0.23	−₹2.38	−₹4.86	₹18.53	₹45.61
	−₹0.23	−₹2.38	−₹4.84	₹18.34	₹45.14
Other comprehensive income — detail
	0.7	0.6	0.4	—	—
	1.0	0.8	0.6	—	—
	0.3	0.3	0.2	—	—
	—	—	—	−0.2	0.6
	—	−2.8	—	26.3	63.9
Per share — as-filed variants
	−₹0.23	−₹2.38	−₹4.86	₹18.53	₹45.61
	−₹0.23	−₹2.38	−₹4.84	₹18.34	₹45.14
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	199	208	235	229	262
	68.1%	66.9%	70.2%	70.0%	79.0%
Adjusted (ex-exceptional items) — derived
	−4.3	−0.2	9.6	39.1	92.8
	0.0	0.0	−9.9	0.0	−3.4
	−0.3	−3.4	2.9	26.3	67.0
	−₹0.23	−₹2.38	₹2.06	₹18.53	₹47.33

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

CHEMFAB₹293.75

Chemfab Alkalis Limited

· Chemicals

Annual Quarterly₹ CrorePeersPRIMO PLASTIBLEN MANORG KRONOX JAYAGROGN LORDSCHLO DMCC SRHHYPOLTDMcap ₹422 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/09/2026
Revenue from Operations	331.4	327.3	334.4	311.0	291.7
Other Income	5.5	8.5	7.1	8.7	8.0
Total Income	336.9	335.8	341.5	319.7	299.7
Expenses
+ Cost of Materials Consumed	48.4	73.6	102.1	95.0	95.1
+ Purchases of Stock-in-Trade	24.9	22.1	7.4	2.7	2.8
+ Changes in Inventories	-3.6	2.4	-9.8	5.3	-4.8
+ Employee Benefit Expense	19.3	23.4	25.5	26.3	26.9
+ Finance Costs	0.2	0.9	4.9	7.7	8.8
+ Depreciation & Amortisation	22.9	22.4	36.3	28.4	31.1
+ Other Expenses	131.9	151.9	165.5	154.5	144.0
Total Expenses	244.1	296.7	331.9	319.9	304.0
EBITDA	110.5	53.9	43.7	27.2	27.6
EBIT	87.5	31.5	7.4	-1.2	-3.5
Profit
PBT before Exceptional Items	92.8	39.1	9.6	-0.2	-4.3
+ Exceptional Items	-3.4	0.0	-9.9	0.0	0.0
Pretax Income	89.4	39.1	-0.3	-0.2	-4.3
+ Current Tax	16.1	7.7	3.8	1.9	0.1
+ Deferred Tax	8.8	5.2	2.9	1.3	-4.1
Tax Expense	24.9	12.8	6.6	3.2	-3.9
Net Income	64.6	26.3	-6.9	-3.4	-0.3
+ Net Income — Continuing Ops	64.6	26.3	-6.9	-3.4	-0.3
+ Other Comprehensive Income	-0.6	0.2	0.4	0.6	0.7
Total Comprehensive Income	63.9	26.5	-6.6	-2.8	0.4
Net Income to Common	64.6	—	—	-3.4	—
Per Share
Basic EPS	45.61	18.53	-4.86	-2.38	-0.23
Diluted EPS	45.14	18.34	-4.84	-2.38	-0.23
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	0.4	0.6	0.7
+ Items NOT to be Reclassified to P&L	—	—	0.6	0.8	1.0
+ Tax on Items NOT to be Reclassified	—	—	0.2	0.3	0.3
+ Tax on Items NOT to be Reclassified — alt tag	0.6	-0.2	—	—	—
Comprehensive Income — Owners of Parent	63.9	26.3	—	-2.8	—
Per Share — as-filed variants
Basic EPS — Continuing Operations	45.61	18.53	-4.86	-2.38	-0.23
Diluted EPS — Continuing Operations	45.14	18.34	-4.84	-2.38	-0.23
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	261.7	229.1	234.7	208.1	198.5
Gross Margin %	78.97	70.01	70.20	66.89	68.06
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	92.8	39.1	9.6	-0.2	-4.3
− Exceptional Items (reconciliation)	-3.4	0.0	-9.9	0.0	0.0
Net Income Adj (tax-effected)	67.0	26.3	2.9	-3.4	-0.3
EPS Adj	47.33	18.53	2.06	-2.38	-0.23
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	10.00	10.00	10.00	10.00	10.00
Paid Up Equity Capital	14.2	14.2	14.4	14.4	14.4

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.